Article
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.
Gastroenterology - 1 Dec 2003
Lau George K K, Yiu Harry H Y, Fong Daniel Y T, Cheng Hoi-Ching, Au Wing-Yan, Lai Lydia S F, Cheung Micheal, Zhang Hai-Ying, Lie Albert, Ngan Roger, Liang Raymond
Abstract excerpt
BACKGROUND & AIMS: Hepatitis B virus reactivation is a serious cause of morbidity and mortality in hepatitis B surface antigen-positive patients treated with chemotherapy. We compared the efficacy of early and deferred preemptive lamivudine therapy in reducing the incidence of hepatitis due to hepatitis B virus reactivation in hepatitis B surface antigen-positive lymphoma patients treated with chemotherapy....
Topics
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents
- DNA, Viral
- Female
- Follow-Up Studies
- Hepatitis B
- Hepatitis B virus
- Humans
- Lamivudine